RxDoctor Payments Data

Robin Friedman-Musicante, MD

Dermatopathology · Memphis, TNNPI 1700853520

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 298 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 25.9% of the total.

$5,692in general payments, 2019–2025

Across 298 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Sanofi$788
  • Johnson & Johnson$763
  • E.r. Squibb & Sons, L.L.C.$332
  • Genentech USA, Inc.$272
  • Solta Medical, A Division Of Bausch Health US, LLC$265
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$5,49296%
  • Education$2004%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,692 in reported general payments places this provider in the 75th percentile of 20 dermatopathology providers in Tennessee.

See all dermatopathology providers in Tennessee

Medicare billing

Part B allowed, 2024
$1,293,097
Medicare patients
1,116
Services billed
7,757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil67$4,256
Clobetasol Propionate30$1,189
Doxycycline Hyclate62$1,180
Mupirocin154$1,117
Imiquimod37$830
Triamcinolone Acetonide45$745
Fluocinolone Acetonide Oil17$651
Ketoconazole48$544
Metronidazole11$518
Minoxidil36$317
Cephalexin23$218
CiclopiroxCiclopirox Olamine12$205
ValacyclovirValacyclovir Hcl29$200
Hydrocortisone25$194
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$141

Paid to pharmacies, not to this prescriber.

Other dermatopathology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →